Smith & Nephew PLC Q2 2019 Earnings Call Summary - Thomson StreetEvents

Smith & Nephew PLC Q2 2019 Earnings Call Summary

Smith & Nephew PLC Q2 2019 Earnings Call Summary - Thomson StreetEvents
Smith & Nephew PLC Q2 2019 Earnings Call Summary
Published Jul 31, 2019
Published Jul 31, 2019
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of SN.L earnings conference call or presentation 31-Jul-19 7:30am GMT

  
Report Type:

Brief

Source:
Company:
Ticker
SN.L
Time
7:30am GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Thomas M. Jones - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : I have 3 hopefully not too long ones. The first one, and apologies if I missed this because I missed the first 10 minutes of the call, but the Wound Care business, if you could give us any color on when you might expect that business to return to a positive growth rate, that will be helpful. Again, apologies if you've already said it, but I missed it. Second question, Namal, just wondering how you're thinking about the Bioventus JV at the moment. It sort of sits there. It's not an insignificant business in value terms, but it doesn't really do much for your P&L and it doesn't really get much if you look in from an investor perspective either. So just wondering whether the -- what your thoughts are on that and whether the capital could be better put to use elsewhere in the business. And then the last question which is a bit of a bigger one, for those of us that have followed Smith+ Nephew long enough, we've seen good periods of growth. But then the old adage, "3 steps forward, 2 steps back", kicks in and something goes wrong somewhere. It's pretty clear to us as observers that we can see all the things that are going well and all the positive changes you've made. But I think it would certainly help us and investors get a bit more comfort that this growth is sustainable if you could give us a little bit more color on what you've done around risk management about how you've maybe changed the business in ways that prevents some of the slip-ups that have always stymied Smith+ Nephew's growth in the long term in the past from happening again. I know it's a bit of a -- sort of an intangible question, but it does weigh on the investors' minds. We're seeing these good growth coming through and lots of people are starting to ask, "When is the next slip-up coming and what have they done to prevent that happening?"

Table Of Contents

Full Year 2019 Smith & Nephew PLC Earnings Call Summary – 2020-02-20 – US$ 54.00 – Edited Brief of SN.L earnings conference call or presentation 20-Feb-20 9:00am GMT

Full Year 2019 Smith & Nephew PLC Earnings Call Transcript – 2020-02-20 – US$ 54.00 – Edited Transcript of SN.L earnings conference call or presentation 20-Feb-20 9:00am GMT

Q3 2019 Smith & Nephew PLC Trading Statement Call Summary – 2019-10-31 – US$ 54.00 – Edited Brief of SN.L sales update conference call or presentation 31-Oct-19 10:00am GMT

Q3 2019 Smith & Nephew PLC Trading Statement Call Transcript – 2019-10-31 – US$ 54.00 – Edited Transcript of SN.L sales update conference call or presentation 31-Oct-19 10:00am GMT

Smith & Nephew PLC Q2 2019 Earnings Call Transcript – 2019-07-31 – US$ 54.00 – Edited Transcript of SN.L earnings conference call or presentation 31-Jul-19 7:30am GMT

Q1 2019 Smith & Nephew PLC Trading Statement Call Summary – 2019-05-02 – US$ 54.00 – Edited Brief of SN.L sales update conference call or presentation 2-May-19 7:30am GMT

Q1 2019 Smith & Nephew PLC Trading Statement Call Transcript – 2019-05-02 – US$ 54.00 – Edited Transcript of SN.L sales update conference call or presentation 2-May-19 7:30am GMT

Smith & Nephew PLC to Acquire Osiris Therapeutics Inc Call Summary – 2019-03-12 – US$ 54.00 – Edited Brief of SN.L M&A conference call or presentation 12-Mar-19 2:30pm GMT

Smith & Nephew PLC to Acquire Osiris Therapeutics Inc Call Transcript – 2019-03-12 – US$ 54.00 – Edited Transcript of SN.L M&A conference call or presentation 12-Mar-19 2:30pm GMT

Smith & Nephew PLC Q4 2018 Earnings Call Summary – 2019-02-07 – US$ 54.00 – Edited Brief of SN.L earnings conference call or presentation 7-Feb-19 8:30am GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Smith & Nephew PLC Q2 2019 Earnings Call Summary" Jul 31, 2019. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2019-Smith-Nephew-PLC-Earnings-Call-B12619976>
  
APA:
Thomson StreetEvents. (2019). Smith & Nephew PLC Q2 2019 Earnings Call Summary Jul 31, 2019. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2019-Smith-Nephew-PLC-Earnings-Call-B12619976>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.